Nivomab Injection 100 mg/10 ml contains Nivolumab, a monoclonal antibody classified as an immune checkpoint inhibitor. It is used in oncology to treat various advanced and metastatic cancers by enhancing the body’s immune response against cancer cells. Nivolumab targets the PD-1 receptor, helping immune cells recognize and destroy tumor cells more effectively.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Nivolumab
• Strength: 100 mg per 10 ml vial

Mechanism of Action

Nivolumab is a PD-1 (programmed death-1) receptor blocker. Cancer cells often evade immune detection by activating PD-1 pathways that suppress T-cell activity. By inhibiting PD-1, Nivolumab restores immune system function, enabling T-cells to identify and attack cancer cells, leading to tumor reduction or disease control.

Indications

Nivomab Injection is indicated for the treatment of:

• Metastatic melanoma
• Non-small cell lung cancer (NSCLC)
• Renal cell carcinoma (kidney cancer)
• Classical Hodgkin lymphoma
• Head and neck squamous cell carcinoma
• Other malignancies as determined by an oncologist

Dosage and Administration

• Administered intravenously only by qualified healthcare professionals
• Dosage depends on cancer type, patient weight, and treatment protocol
• Given as an infusion in a clinical setting under strict supervision
• Treatment duration is based on response and tolerability

Benefits

• Enhances the immune system’s ability to fight cancer
• Provides targeted immunotherapy with durable clinical responses
• Used in multiple advanced-stage cancers
• Offers an innovative treatment approach in oncology care

Possible Side Effects

As an immune checkpoint inhibitor, Nivolumab may cause immune-related adverse effects, including:

• Fatigue
• Skin rash or itching
• Diarrhea or colitis
• Liver inflammation (hepatitis)
• Lung inflammation (pneumonitis)
• Endocrine disorders (thyroid, adrenal, or pituitary dysfunction)

Serious immune reactions may occur and require immediate medical attention.

Precautions and Warnings

• Must be administered under the supervision of an oncology specialist
• Regular monitoring of liver, kidney, and thyroid function is required
• Use with caution in patients with autoimmune disorders
• Not recommended during pregnancy or breastfeeding
• Prompt reporting of any unusual symptoms is essential

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children

Conclusion

Nivomab Injection 100 mg/10 ml (Nivolumab) is an advanced immunotherapy used in the treatment of various cancers. By activating the immune system against tumor cells, it provides an effective option for managing advanced malignancies under strict medical supervision.